| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-106 |
Sentence |
denotes |
Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. |
| T1 |
0-106 |
Sentence |
denotes |
Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. |
| T2 |
107-273 |
Sentence |
denotes |
A monoclonal IgM antibody, 4.2, reacting with a surface antigen expressed on most human melanomas (Yeh, M.-I., Hellström, I., Abe, K., Hakomori, S., and Hellström, K. |
| T2 |
107-273 |
Sentence |
denotes |
A monoclonal IgM antibody, 4.2, reacting with a surface antigen expressed on most human melanomas (Yeh, M.-I., Hellström, I., Abe, K., Hakomori, S., and Hellström, K. |
| T3 |
274-288 |
Sentence |
denotes |
E. (1982) Int. |
| T3 |
274-288 |
Sentence |
denotes |
E. (1982) Int. |
| T4 |
289-291 |
Sentence |
denotes |
J. |
| T4 |
289-291 |
Sentence |
denotes |
J. |
| T5 |
292-481 |
Sentence |
denotes |
Cancer, 29, 269-275) was shown to be directed to a ganglioside with the carbohydrate structure NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer. |
| T5 |
292-481 |
Sentence |
denotes |
Cancer, 29, 269-275) was shown to be directed to a ganglioside with the carbohydrate structure NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer. |
| T6 |
482-784 |
Sentence |
denotes |
The carbohydrate structure, established by enzymatic degradation and methylation analysis with mass spectrometry, is identical with that of brain GD3 ganglioside, but its ceramide is characterized by a predominance of longer chain fatty acids, in contrast to brain GD3 that has mainly C18:0 fatty acid. |
| T6 |
482-784 |
Sentence |
denotes |
The carbohydrate structure, established by enzymatic degradation and methylation analysis with mass spectrometry, is identical with that of brain GD3 ganglioside, but its ceramide is characterized by a predominance of longer chain fatty acids, in contrast to brain GD3 that has mainly C18:0 fatty acid. |
| T7 |
785-985 |
Sentence |
denotes |
The antibody did not react with various other gangliosides, including those having the same terminal sugar sequence (NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal) as GD3, such as GT1a and GQ1b. |
| T7 |
785-985 |
Sentence |
denotes |
The antibody did not react with various other gangliosides, including those having the same terminal sugar sequence (NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal) as GD3, such as GT1a and GQ1b. |
| T8 |
986-1172 |
Sentence |
denotes |
Its specificity is therefore restricted to the NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc leads to Cer sequence, including the innermost sugar, Glc residue. |
| T8 |
986-1172 |
Sentence |
denotes |
Its specificity is therefore restricted to the NeuAc alpha 2 leads to 8NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc leads to Cer sequence, including the innermost sugar, Glc residue. |